Vaccines | Notable Papers of COVID-19 Vaccines and Vaccination in 2024
We are pleased to present the highly viewed and/or cited papers published by Vaccines (ISSN: 2076-393X) in 2024 on the topic of COVID-19 Vaccines and Vaccination. We would like to take this opportunity to acknowledge the exceptional individuals and teams whose work serves as an inspiration to fellow researchers and significantly impacts the field of COVID-19 vaccine-related research. We are grateful to the journal’s Section Editor-in-Chief, Prof. Dr. Luis Martinez-Sobrido, for his valuable assistance in selecting these papers. We invite you to explore the remarkable works listed below.
1. “Comparative Analysis of Vaccine-Induced Neutralizing Antibodies against the Alpha, Beta, Delta, and Omicron Variants of SARS-CoV-2”
by Philipp Girl, Heiner von Buttlar, Enrico Mantel, Markus H. Antwerpen, Roman Wölfel and Katharina Müller
Vaccines 2024, 12(5), 515; https://doi.org/10.3390/vaccines12050515
Available online: https://www.mdpi.com/2076-393X/12/5/515
2. “Mucosal Vaccination with a Newcastle Disease Virus-Vectored Vaccine Reduces Viral Loads in SARS-CoV-2-Infected Cynomolgus Macaques”
by Bryce M. Warner, Mable Chan, Nikesh Tailor, Robert Vendramelli, Jonathan Audet, Courtney Meilleur, Thang Truong, Lauren Garnett, Marnie Willman, Geoff Soule et al.
Vaccines 2024, 12(4), 404; https://doi.org/10.3390/vaccines12040404
Available online: https://www.mdpi.com/2076-393X/12/4/404
3. “Hybrid Immunity Improves the Immune Response after the Fourth COVID-19 Vaccine Dose in Individuals with Medical Conditions Predisposing to Severe COVID-19”
by Nina Ekström, Tuija M. Leino, Aapo Juutinen, Toni Lehtonen, Anu Haveri, Oona Liedes, Saimi Vara, Heini Salo, Arto A. Palmu, Hanna Nohynek et al.
Vaccines 2024, 12(3), 247; https://doi.org/10.3390/vaccines12030247
Available online: https://www.mdpi.com/2076-393X/12/3/247
4. “Impact of Nirsevimab Immunization on Pediatric Hospitalization Rates: A Systematic Review and Meta-Analysis (2024)”
by Matteo Riccò, Antonio Cascio, Silvia Corrado, Marco Bottazzoli, Federico Marchesi, Renata Gili, Pasquale Gianluca Giuri, Davide Gori and Paolo Manzoni
Vaccines 2024, 12(6), 640; https://doi.org/10.3390/vaccines12060640
Available online: https://www.mdpi.com/2076-393X/12/6/640
5. “Induction of Superior Systemic and Mucosal Protective Immunity to SARS-CoV-2 by Nasal Administration of a VSV–ΔG–Spike Vaccine”
by Yfat Yahalom-Ronen, Sharon Melamed, Boaz Politi, Noam Erez, Hadas Tamir, Liat Bar-On, Julia Ryvkin, Dena Leshkowitz, Ofir Israeli, Shay Weiss et al.
Vaccines 2024, 12(5), 491; https://doi.org/10.3390/vaccines12050491
Available online: https://www.mdpi.com/2076-393X/12/5/491
6. “Longitudinal Assessment of BNT162b2- and mRNA-1273-Induced Anti-SARS-CoV-2 Spike IgG Levels and Avidity Following Three Doses of Vaccination”
by Jimmie L. Bullock, Jr., Thomas E. Hickey, Troy J. Kemp, Jordan Metz, Sarah Loftus, Katarzyna Haynesworth, Nicholas Castro, Brian T. Luke, Douglas R. Lowy and Ligia A. Pinto
Vaccines 2024, 12(5), 516; https://doi.org/10.3390/vaccines12050516
Available online: https://www.mdpi.com/2076-393X/12/5/516
7. “Integrating Digital Health Solutions with Immunization Strategies: Improving Immunization Coverage and Monitoring in the Post-COVID-19 Era”
by Grazia Pavia, Francesco Branda, Alessandra Ciccozzi, Chiara Romano, Chiara Locci, Ilenia Azzena, Noemi Pascale, Nadia Marascio, Angela Quirino, Giovanni Matera et al.
Vaccines 2024, 12(8), 847; https://doi.org/10.3390/vaccines12080847
Available online: https://www.mdpi.com/2076-393X/12/8/847
8. “Intranasally inoculated SARS-CoV-2 spike protein combined with mucoadhesive polymer induces broad and long-lasting immunity”
by Tomoko Honda, Sakiko Toyama, Yusuke Matsumoto, Takahiro Sanada, Fumihiko Yasui, Aya Koseki, Risa Kono, Naoki Yamamoto, Takashi Kamishita, Natsumi Kodake et al.
Vaccines 2024, 12(7), 794; https://doi.org/10.3390/vaccines12070794
Available online: https://www.mdpi.com/2076-393X/12/7/794
9. “COVID-19 Booster Vaccination Status and Long COVID in the United States: A Nationally Representative Cross-Sectional Study”
by Jamie L. Romeiser and Kelsey Schoeneck
Vaccines 2024, 12(6), 688; https://doi.org/10.3390/vaccines12060688
Available online: https://www.mdpi.com/2076-393X/12/6/688
10. “Antigen-Heterologous Vaccination Regimen Triggers Alternate Antibody Targeting in SARS-CoV-2-DNA-Vaccinated Mice”
by Anders Frische, Karen Angeliki Krogfelt, Anders Fomsgaard and Ria Lassaunière
Vaccines 2024, 12(3), 218; https://doi.org/10.3390/vaccines12030218
Available online: https://www.mdpi.com/2076-393X/12/3/218